495 related articles for article (PubMed ID: 17087947)
21. Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas.
Solomon SD; Pfeffer MA; McMurray JJ; Fowler R; Finn P; Levin B; Eagle C; Hawk E; Lechuga M; Zauber AG; Bertagnolli MM; Arber N; Wittes J;
Circulation; 2006 Sep; 114(10):1028-35. PubMed ID: 16943394
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial.
Baron JA; Sandler RS; Bresalier RS; Lanas A; Morton DG; Riddell R; Iverson ER; Demets DL
Lancet; 2008 Nov; 372(9651):1756-64. PubMed ID: 18922570
[TBL] [Abstract][Full Text] [Related]
23. Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.
Midgley RS; McConkey CC; Johnstone EC; Dunn JA; Smith JL; Grumett SA; Julier P; Iveson C; Yanagisawa Y; Warren B; Langman MJ; Kerr DJ
J Clin Oncol; 2010 Oct; 28(30):4575-80. PubMed ID: 20837956
[TBL] [Abstract][Full Text] [Related]
24. [Selective cyclooxygenase-2 inhibitors for the prevention of colorectal adenomas: a meta-analysis].
Jin XF; Tong JL; Ran ZH
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1958-61. PubMed ID: 17923032
[TBL] [Abstract][Full Text] [Related]
25. The efficacy of rofecoxib 50 mg and hydrocodone/acetaminophen 7.5/750 mg in patients with post-arthroscopic pain.
Chelly JE; Nissen CW; Rodgers AJ; Smugar SS; Tershakovec AM
Curr Med Res Opin; 2007 Jan; 23(1):195-206. PubMed ID: 17207303
[TBL] [Abstract][Full Text] [Related]
26. Combining paracetamol with a selective cyclooxygenase-2 inhibitor for acute pain relief after third molar surgery: a randomized, double-blind, placebo-controlled study.
Haglund B; von Bültzingslöwen I
Eur J Oral Sci; 2006 Aug; 114(4):293-301. PubMed ID: 16911100
[TBL] [Abstract][Full Text] [Related]
27. Chemoprevention of colorectal neoplasia: advances and controversies (the COX-2 story).
Bresalier RS
Curr Opin Gastroenterol; 2007 Jan; 23(1):44-7. PubMed ID: 17133084
[TBL] [Abstract][Full Text] [Related]
28. Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study.
Shimizu M; Fukutomi Y; Ninomiya M; Nagura K; Kato T; Araki H; Suganuma M; Fujiki H; Moriwaki H
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3020-5. PubMed ID: 18990744
[TBL] [Abstract][Full Text] [Related]
29. A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients.
Higuchi T; Iwama T; Yoshinaga K; Toyooka M; Taketo MM; Sugihara K
Clin Cancer Res; 2003 Oct; 9(13):4756-60. PubMed ID: 14581346
[TBL] [Abstract][Full Text] [Related]
30. Celecoxib for the prevention of sporadic colorectal adenomas.
Bertagnolli MM; Eagle CJ; Zauber AG; Redston M; Solomon SD; Kim K; Tang J; Rosenstein RB; Wittes J; Corle D; Hess TM; Woloj GM; Boisserie F; Anderson WF; Viner JL; Bagheri D; Burn J; Chung DC; Dewar T; Foley TR; Hoffman N; Macrae F; Pruitt RE; Saltzman JR; Salzberg B; Sylwestrowicz T; Gordon GB; Hawk ET;
N Engl J Med; 2006 Aug; 355(9):873-84. PubMed ID: 16943400
[TBL] [Abstract][Full Text] [Related]
31. Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2.
Fries S; Grosser T; Price TS; Lawson JA; Kapoor S; DeMarco S; Pletcher MT; Wiltshire T; FitzGerald GA
Gastroenterology; 2006 Jan; 130(1):55-64. PubMed ID: 16401468
[TBL] [Abstract][Full Text] [Related]
32. The trade-off between cardiovascular and gastrointestinal effects of rofecoxib.
Florentinus SR; Heerdink ER; de Boer A; van Dijk L; Leufkens HG
Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):437-41. PubMed ID: 15937867
[TBL] [Abstract][Full Text] [Related]
33. More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib.
Hinz B; Dormann H; Brune K
Arthritis Rheum; 2006 Jan; 54(1):282-91. PubMed ID: 16385545
[TBL] [Abstract][Full Text] [Related]
34. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study.
Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
[TBL] [Abstract][Full Text] [Related]
36. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
Grohs JG; Schmidt M; Wanivenhaus A
Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of metachronous colorectal adenomas found during long-term follow-up: analysis of four subsequent generations of adenoma recurrence.
Nusko G; Hahn EG; Mansmann U
Scand J Gastroenterol; 2009; 44(6):736-44. PubMed ID: 19277927
[TBL] [Abstract][Full Text] [Related]
38. [Assessment of the number of cardio- and cerebrovascular events due to rofecoxib (Vioxx) in Germany between 2001 and 2004].
Sawicki PT; Bender R; Selke GW; Klauber J; Gutschmidt S
Med Klin (Munich); 2006 Mar; 101(3):191-7. PubMed ID: 16648975
[TBL] [Abstract][Full Text] [Related]
39. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.
Higurashi T; Hosono K; Takahashi H; Komiya Y; Umezawa S; Sakai E; Uchiyama T; Taniguchi L; Hata Y; Uchiyama S; Hattori A; Nagase H; Kessoku T; Arimoto J; Matsuhashi N; Inayama Y; Yamanaka S; Taguri M; Nakajima A
Lancet Oncol; 2016 Apr; 17(4):475-483. PubMed ID: 26947328
[TBL] [Abstract][Full Text] [Related]
40. Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States).
Kim S; Baron JA; Mott LA; Burke CA; Church TR; McKeown-Eyssen GE; Cole BF; Haile RW; Sandler RS
Cancer Causes Control; 2006 Dec; 17(10):1299-304. PubMed ID: 17111262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
